WHO discontinued hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
On Jul. 2, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced a publication in the…
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Company’s Phase 1b clinical trial…
On Jun. 29, 2020, National Institutes of Health (NIH) researchers announced they had discovered that Mediterranean populations may…
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
On Jun. 23, 2020, scientists at Scripps Research reported that some common strains of influenza have the potential…
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…